Ashmore SICAV in respect of Ashmore SICAV Emerging Markets Active Equity Fund — Form D/A
Ashmore SICAV in respect of Ashmore SICAV Emerging Markets Active Equity Fund of LEUDELANGE, N4, a pooled investment fund, filed a Form D amendment with the SEC on 2022-10-05. $71.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-10-05
- Form: D/A
- Accession: 0001848491-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $71.5M
- Minimum investment: $5K
- Investors: 1
- Date of first sale: 2020-06-30
- Security types: fund interests
- SEC file number: 021-390922
Issuer
- Name: Ashmore SICAV in respect of Ashmore SICAV Emerging Markets Active Equity Fund
- CIK: 0001848491
- Entity type: Other
- Jurisdiction: LUXEMBOURG
- Address: 10, RUE DU CHATEAU D'EAU, LEUDELANGE, N4, L-3364
- Phone: 352-27-62-22-1
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| CLAUDE KREMER | Director | LUXEMBOURG, N4 |
| JURAJ PEKAR | Director | LONDON, X0 |
| STEPHEN HICKS | Director | ESSEX, X0 |
| ISABELLE LEBBE | Director | LUXEMBOURG, N4 |
| MATTHEW HILL | Director | Houston, TX |
| DENNIS ROBERTSON | Director | MAMER, N4 |
| JOHN GREGORY | Director | LONDON, X0 |
Other filings by this issuer (3)
More